IMS Company Profiles - Report Buyer
Share Embed Flag
Download ePaper

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer IMS Company Profiles - Report Buyer

reportbuyer.com
from reportbuyer.com More from this publisher
06.03.2013 Views

IMS COM PANY PRO FILES NOVARTIS IMS Sales Data Pharmaceutical Sales by Geographical Region and Leading Countries Country Share of Regional Corporate Sales % Percentage Growth Sep 07/Sep 08 USD USD FIXED RATE TOTAL SALES 100.0 8 1 EUROPE 41.6 22 8 GERMANY 28.1 22 8 FRANCE 14.8 21 7 ITALY 8.6 22 8 SPAIN 7.8 23 9 UNITED KINGDOM 5.8 8 8 NORTH AMERICA 37.1 -10 -11 U.S.A. 92.6 -12 -12 CANADA 7.4 22 11 ASIA, AFRICA & AUSTRALASIA 16.2 20 11 JAPAN 44.5 19 7 TURKEY 14.0 23 10 AUSTRALIA 8.5 40 25 KOREA 5.5 9 15 CHINA HOSPITAL 3.8 29 19 LATIN AMERICA 5.0 25 15 BRAZIL RETAIL 44.5 44 21 MEXICO RETAIL 21.2 2 -1 VENEZUELA RETAIL 11.2 52 52 ARGENTINA RETAIL 6.1 14 14 PUERTO RICO 5.9 3 3 The com pany’s phar ma ceu ti cal sales are an a lyzed in terms of geo graph ical re gion, and within each re - gion the ma jor coun tries pre sented. Sales data cov ers the twelve months to Sep tem ber 2008. See Ap - pen dix for coun try universe sourced. Sales and growth for the au dited Latin Amer i can coun tries are pre sented in US dol lars only. The de ci sion for con ver sion to US dol lars was due to ex ces sive in fla tion and sub se quent de val u a tions lead ing to both lo cal cur rency and ex change rates ex ceed ing the field sizes avail able for them on the MIDAS database. Novartis Total Sales by Top Five Markets Source: IMS Health Others 37% Japan 7% Italy 4% France 6% Sales by Top 5 Markets USA 34% Germany 12% © 2009 IMS Health In cor po rated or its af fil i ates Page 118

IMS COM PANY PRO FILES NOVARTIS Pharmaceutical Sales by Country and Subsidiary Share of Regional Corporate Sales % Percentage Growth Sep 07/Sep 08 USD USD FIXED RATE TOTAL SALES 100.0 8 1 U.S.A. 34.4 -12 -12 NOVARTIS RX 73.0 -11 -11 SANDOZ 21.9 -11 -11 NOVARTIS CONS HLTH 2.9 -8 -8 NOVARTIS VACCINE 1.6 -46 -46 NOVARTIS VISION 0.6 7 7 GERMANY 11.7 22 8 NOVARTIS PHARMA 39.8 26 12 HEXAL 36.4 26 12 NOVARTIS VACCINES 7.4 -6 -17 1A PHARMA 5.8 34 19 SANDOZ 5.4 14 1 NOVARTIS CONS.HEAL 5.2 17 4 NOVARTIS/P.FABRE 0.1 7 -5 JAPAN 7.2 19 7 NOVARTIS PHARMA JA 98.8 18 7 SANDOZ JAPAN 1.2 29 16 FRANCE 6.2 21 7 NOVARTIS PHARMA 74.9 21 7 SANDOZ 19.7 23 9 NOVARTIS SANTE FAM 4.5 10 -3 CHIRON FRANCE 0.8 32 16 NOVARTIS VACC&DIAG 0.1 383 333 DIETETIQ ET SANTE 0.1 -4 -15 ITALY 3.6 22 8 NOVARTIS FARMA 70.4 19 5 NOVARTIS CONS.HEAL 14.8 16 2 SANDOZ 6.1 51 34 HEXAL 5.6 38 22 NOVARTIS VACCINES 2.8 90 68 POZZI 0.2 -41 -48 SCLAVO DIAGNOSTICS 0.1 40 24 SPAIN 3.2 23 9 NOVARTIS 82.3 25 11 NOVARTIS CONS HEAL 6.5 20 6 SANDOZ FARMACEUTIC 5.9 25 11 BEXAL FARMACEUTIC 4.6 -2 -13 ACOST COMER GEN PH 0.6 23 9 CANADA 2.7 22 11 NOVARTIS PHARMA 63.6 17 6 SANDOZ CANADA INC 29.1 38 26 NOVARTIS CON HEALT 6.6 7 -3 CIBA VISION OPTICS 0.7 48 35 UNITED KINGDOM 2.4 8 8 NOVARTIS PHARM UK 82.9 15 15 SANDOZ 10.0 -16 -17 NOVARTIS CONSUMER 5.7 -17 -17 CHIRON UK 0.7 30 29 CIBAVISION 0.4 29 29 CHIRON VACC EVANS 0.3 17 17 © 2009 IMS Health In cor po rated or its af fil i ates Page 119

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS<br />

Pharmaceutical Sales by Country and Subsidiary<br />

Share of<br />

Regional<br />

Corporate Sales<br />

%<br />

Percentage<br />

Growth Sep<br />

07/Sep 08<br />

USD USD FIXED<br />

RATE<br />

TOTAL SALES 100.0 8 1<br />

U.S.A. 34.4 -12 -12<br />

NOVARTIS RX 73.0 -11 -11<br />

SANDOZ 21.9 -11 -11<br />

NOVARTIS CONS HLTH 2.9 -8 -8<br />

NOVARTIS VACCINE 1.6 -46 -46<br />

NOVARTIS VISION 0.6 7 7<br />

GERMANY 11.7 22 8<br />

NOVARTIS PHARMA 39.8 26 12<br />

HEXAL 36.4 26 12<br />

NOVARTIS VACCINES 7.4 -6 -17<br />

1A PHARMA 5.8 34 19<br />

SANDOZ 5.4 14 1<br />

NOVARTIS CONS.HEAL 5.2 17 4<br />

NOVARTIS/P.FABRE 0.1 7 -5<br />

JAPAN 7.2 19 7<br />

NOVARTIS PHARMA JA 98.8 18 7<br />

SANDOZ JAPAN 1.2 29 16<br />

FRANCE 6.2 21 7<br />

NOVARTIS PHARMA 74.9 21 7<br />

SANDOZ 19.7 23 9<br />

NOVARTIS SANTE FAM 4.5 10 -3<br />

CHIRON FRANCE 0.8 32 16<br />

NOVARTIS VACC&DIAG 0.1 383 333<br />

DIETETIQ ET SANTE 0.1 -4 -15<br />

ITALY 3.6 22 8<br />

NOVARTIS FARMA 70.4 19 5<br />

NOVARTIS CONS.HEAL 14.8 16 2<br />

SANDOZ 6.1 51 34<br />

HEXAL 5.6 38 22<br />

NOVARTIS VACCINES 2.8 90 68<br />

POZZI 0.2 -41 -48<br />

SCLAVO DIAGNOSTICS 0.1 40 24<br />

SPAIN 3.2 23 9<br />

NOVARTIS 82.3 25 11<br />

NOVARTIS CONS HEAL 6.5 20 6<br />

SANDOZ FARMACEUTIC 5.9 25 11<br />

BEXAL FARMACEUTIC 4.6 -2 -13<br />

ACOST COMER GEN PH 0.6 23 9<br />

CANADA 2.7 22 11<br />

NOVARTIS PHARMA 63.6 17 6<br />

SANDOZ CANADA INC 29.1 38 26<br />

NOVARTIS CON HEALT 6.6 7 -3<br />

CIBA VISION OPTICS 0.7 48 35<br />

UNITED KINGDOM 2.4 8 8<br />

NOVARTIS PHARM UK 82.9 15 15<br />

SANDOZ 10.0 -16 -17<br />

NOVARTIS CONSUMER 5.7 -17 -17<br />

CHIRON UK 0.7 30 29<br />

CIBAVISION 0.4 29 29<br />

CHIRON VACC EVANS 0.3 17 17<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 119

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!